Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
986.8 INR | -0.32% | +0.13% | +21.56% |
05-08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
05-08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.56% | 2.12B | |
+31.69% | 588B | |
-3.42% | 364B | |
+18.02% | 326B | |
+4.27% | 285B | |
+15.53% | 239B | |
+10.04% | 210B | |
-7.32% | 200B | |
+8.12% | 167B | |
-1.42% | 161B |
- Stock Market
- Equities
- NATCOPHARM Stock
- News NATCO Pharma Limited
- Transcript : NATCO Pharma Limited, Q1 2024 Earnings Call, Aug 10, 2023